Case ReportInternational Journal of Community Medicine and Public Health

Publication:
When can a skin biopsy reveal Lafora disease

Int J Community Med Public Health. 2025;12(10):4761-4763.DOI10.18203/2394-6040.ijcmph20253282

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Lafora disease (LD) is a rare and particularly severe form of progressive myoclonic epilepsy (PME). It is an autosomal recessive hereditary disorder, with the responsible gene recently localized to chromosome 6q23-27. It is characterized by the onset, between the ages of 6 and 19, of generalized seizures followed by myoclonus. A major intellectual decline develops rapidly and progressively, eventually leading to dementia. Histological examination is essential for confirming the diagnosis of LD. The most practical procedure is a skin biopsy performed in the axillary region, allowing visualization of PAS positive inclusions within the excretory duct cells of the sweat glands-findings that are consistent with Lafora bodies. We report a clinical case of LD in a 16 years old adolescent girl and discuss the diagnostic challenges associated with this condition.

Keywords

Affiliations

  1. Department of Dermatology, CHU Hassan II, Fez, Morocco
  2. Department of Neurology, CHU Hassan II, Fez, Morocco
  3. Department of Anatomical Pathology, CHU Hassan II, Fez, Morocco

Full item record